In this study, we want to learn more about the safety and tolerability of a drug called NX-1607 in adult patients with advanced tumors. We want to see if this new drug may be able to slow the growth of your cancer.

Have you been diagnosed with an advanced cancer that has not responded to or has stopped responding to treatment? Have you had genetic testing done on your cancer? If so you may be able to take park in a research study to observe how certain cancer drugs target tumor DNA. Travel reimbursement provided.

In this study, we will learn more about the safety and effectiveness of a study treatment that is injected into one of the kidneys of patients with Chronic Kidney Disease and Type 2 Diabetes.

Have you been diagnosed with cervical cancer? If so, you may be able to take part in a research study that aims to identify a new non-invasive biomarker (blood test) to 1) detect cervical cancer during screenings and 2) track response to treatment, detect early recurrence and guide personalized treatment decisions. In this study we will measure levels of Circulating Tumor Human Papilloma Virus DNA (ctHPVDNA) levels in the blood and urine of women with newly diagnosed cervical cancer prior to receiving any treatment, and then compare this to the levels in samples collected after treatment (surgery of chemoradiation).

People with Barrett's esophagus are at higher than average risk of developing esophageal cancer. Obeticholic Acid (OCA) is a medication similar to bile acids (a fluid made and released by the liver). OCA binds to a group of cells in the intestine that is believed to have a positive effect on preventing cancer development. The purpose of this study is to compare the safety and effects of OCA with that of a placebo on the risk of developing esophageal cancer in people with Barrett's esophagus.

The purpose of this study is to test the safety of a drug called CA-4948 in combination with gemcitabine and nab-paclitaxel. Gemcitabine and nab-paclitaxel have already been approved by the FDA to be given through a vein in your arm. This study tests different doses of the drug CA-4948 to see which dose is safer for people. There will be about 36 people taking part in this study.

Do you have head and neck cancer or soft tissue sarcoma? Are you planning to have surgery to remove your tumor? You may be able to participate in a research study to determine which therapies may be best for future patients. Compensation provided.

In this study, we want to learn how we can increase awareness and availability of specialty pain care services for Black men. We will do this by asking questions about physical health, access to health care, decision-making, and factors that impact someone's health.

In this study, we want to learn more about the impact of micro-influencers on young adults between ages 18 and 25.

This study is a survey that will provide information about college students access to birth control on different campuses. By responding to this survey you will help the research team to find out how on campus pharmacies can contribute to campus health and access to birth control.